Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: An <i>in vitro</i> study.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29657439.
- Also identified by DOI 10.1016/j.jor.2018.01.032 and PMC identifier 5895903.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to examine the influence of topical vancomycin on cell migration and survival of tissue healing cells. Human osteoblasts, myoblasts and fibroblasts were exposed to vancomycin at concentrations of 1, 3, 6, or 12 mg/cm<sup>2</sup> for either a 1-h or 48-h (continuous) duration. Continuous exposure to all vancomycin concentrations significantly reduced cell survival (<22% cells survived) and migration in osteoblasts and myoblasts (P < 0.001). 1-h vancomycin exposure reduced osteoblast and myoblast survival and migration only at 12 mg/cm<sup>2</sup> (P < 0.001). Further <i>in vivo</i> studies are warranted to optimize the dosage of intrawound vancomycin.